https://www.selleckchem.com/peptide/avexitide.html Impaired macroautophagy/autophagy has been implicated in experimental and human nonalcoholic steatohepatitis (NASH). However, the mechanism underlying autophagy dysregulation in NASH is largely unknown. Here, we investigated the role and mechanism of TXNIP/VDUP1 (thioredoxin interacting protein), a key mediator of cellular stress responses, in the pathogenesis of NASH. Hepatic TXNIP expression was upregulated in nonalcoholic fatty liver disease (NAFLD) patients and in methionine choline-deficient (MCD) diet-fed mice, as well as in palmitic acid (PA)-treated hepatocytes. Upregulation of hepatic TXNIP was positively correlated with impaired autophagy, as evidenced by a decreased number of MAP1LC3B/LC3B (microtubule-associated protein 1 light chain 3 beta) puncta and increased SQSTM1/p62 (sequestosome 1) expression. Deletion of the Txnip gene enhanced hepatic steatosis, inflammation, and fibrosis, accompanied by impaired autophagy and fatty acid oxidation (FAO) in MCD diet-fed mice. Mechanistically, TXNIP direct 9; mRNA messenger RNA; MTORC1 mechanistic target of rapamycin kinase complex 1; NAFLD nonalcoholic fatty liver diseases; NASH nonalcoholic steatohepatitis; PA palmitic acid; PPARA/PPARα peroxisome proliferator activated receptor alpha; PPARG/PPARγ peroxisome proliferator activated receptor gamma; qRT-PCR quantitative real-time PCR; RPS6KB1/p70S6K1 ribosomal protein S6 kinase, polypeptide 1; RPTOR regulatory associated protein of MTOR complex 1; SCD1 stearoyl-Coenzyme A desaturase 1; SEM standard error of the mean; siRNA small interfering RNA; SQSTM1/p62 sequestosome 1; TFEB transcription factor EB; TG triglyceride; TGFB/TGF-β transforming growth factor, beta; TIMP1 tissue inhibitor of metalloproteinase 1; TNF/TNF-α tumor necrosis factor; TXNIP/VDUP1 thioredoxin interacting protein; WT wild-type.Endometrial carcinoma (EC) remains one of the most prevalent forms of cancer to impact the female reproductive system,